Showing results (301-310 of 3,965) with videos related to
Sort By:
Pageof 397
Translational Cancer Research|February 4, 2022
Combined immune checkpoint inhibitor and chemotherapy is effective in a patient with ALK rearranged non-small cell lung cancer: a case reportLexin Xia, Hanguang Hu, Wen Li, et al.Translational Cancer Research|February 4, 2022
Established and innovative surgical techniques for the treatment of benign subglottic stenosisMatthias Evermann, Thomas Schweiger, Imme Roesner, et al.Translational Cancer Research|February 4, 2022
Progesterone receptor inhibits the proliferation and invasion of endometrial cancer cells by up regulating Krüppel-like factor 9Xiaofang Yan, Huilin Zhang, Jieqi Ke, et al.Translational Cancer Research|February 4, 2022
Exome sequencing identified six copy number variations as a prediction model for recurrence of primary prostate cancers with distinctive prognosisJie Liu, Jiajun Yan, Ruifang Mao, et al.Translational Cancer Research|February 4, 2022
Nomograms to predict overall and cancer-specific survival in patients with penile cancerWenbo Xu, Feng Qi, Yi Liu, et al.Translational Cancer Research|February 4, 2022
GLUT1/3/4 as novel biomarkers for the prognosis of human breast cancerKai Zeng, Gaoda Ju, Hao Wang, et al.Translational Cancer Research|February 4, 2022
Data independent acquisition-mass spectrometry (DIA-MS)-based comprehensive profiling of bone metastatic cancers revealed molecular fingerprints to assist clinical classifications for bone metastasis of unknown primary (BMUP)Xin Ku, Chunlin Cai, Yan Xu, et al.Translational Cancer Research|February 4, 2022
Establishment of surface marker expression profiles for colorectal cancer stem cells under different conditionsGwo-Che Huang, Chen-Ying Su, You-Cheng Chang, et al.Translational Cancer Research|February 4, 2022
Prognosis value of liver stiffness measurements by 2D-SWE in primary HBV-positive hepatocellular carcinoma following radiofrequency ablationXinxin Xie, Yongqiang YuTranslational Cancer Research|February 4, 2022
MAP kinase-interacting kinase 1 (MNK1) plays as a tumor suppressor in bladder cancerZhuangfei Chen, Kanghua Xiao, Hao Zhang, et al.Pageof 397